|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 10/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings
Export Registrations for Products with Expired Patents
Foreign Agricultural Biotechnology Laws and Regulations
Discussions with EU on Animal Cloning
China Biotechnology Regulations
APEC Agricultural Biotechnology Discussions
Low-Level Presence Foreign Government Policies
Korea Biotechnology Regulations
EU Biotechnology Bilateral Discussions
Turkish Biotechnology Regulations
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems
U.S. Policy on Sustainable Agriculture Standard
American National Standards Institute Sustainable Agriculture Standard (ANSI)
Funding for the USDA
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2011
Biomass Crop Assistance Program (BCAP)
2007 Farm Bill Implementation
BCAP Rulemaking and Environmental Impact Statement
U.S. Government Agriculture Research Funding
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for
FY 2011
Global Food Security Initiative
Funding
S. 3676: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011
U.S. Government Strategy
EPA Regulations on Agricultural Biotechnology
Reauthorization and Implementation of Pesticide Registration Improvement Act
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Genetically Engineered (GE) Animals
Labeling
FDA Approval
Labeling of Genetically Engineered Crops
U.S. Government Policy
U.S. Policy on International Science-Based Regulations
Transpacific Partnership
Fish and Wildlife Service Policy on Planting of Biotech Crops
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR), Food & Drug Administration (FDA), Agriculture - Dept of (USDA), State - Dept of (DOS), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Interior - Dept of (DOI),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Matthew |
OMara |
|
|
|
Bill |
Olson |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Genetically Engineered (GE) Animals
Labeling
FDA Approval
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Bill |
Olson |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. 3607: Department of Homeland Security Appropriations Act for FY 2011
Drug Importation
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Livestock Cloning/Product Labeling
Funding for the USDA (Office of General Counsel , Biotechnology Regulatory Services (APHIS), Animal Care &
Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service),
Agriculture Research Service, Biofuels, Foreign Agricultural Service)
Funding for Biofuels and Bio-based Products
Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical
Path, Regan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure)
Drug Importation
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Funding for Pandemic Influenza Preparedness
Funding for National Institutes of Health
Cures Acceleration Network
Funding for Bioterrorism and Emergency Preparedness
Funding for Biomedical Advanced Research and Development Authority (BARDA)
Funding for Centers for Disease Control and Prevention Vaccine Programs
Drug Importation
Funding for Strategic National Stockpile
S: 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Title XVII Loan Guarantee Program
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005
Funding for Biofuels and Bio-based Products
Funding for Biorefineries
S. 3676: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011
Funding for Biotechnology Research and Development Programs at the Agency for International Development and
Department of State
Funding for the Bureau of Economic, Energy, and Business Affairs (EEB) at the U.S. Department of State
Funding for Global Food Security Initiative
H.R.1586 / S.A.4575: Supplemental Education, Jobs and Medicaid Assistance Act of 2010
Funding for Biofuels and Bio-based Products
Generic Patent Settlements
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Funding for Biomedical Advanced Research and Development Authority (BARDA)
S. 3677: Financial Services and General Government Appropriations Act of 2011
Generic Patent Settlements
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
Generic Drug Patent Settlements
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Average Manufacturer Price Calculations
Funding for Biomedical Advanced Research and Development Authority (BARDA)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Patrick |
Carroll |
|
|
|
Matt |
Carr |
|
|
|
Laurel |
Todd |
|
|
|
Anna |
Weinstein |
|
|
|
Matthew |
Schumaker |
|
|
|
Bill |
Olson |
|
|
|
Andrew |
Emmett |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
David |
Edwards |
|
|
|
Cartier |
Esham |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA), State - Dept of (DOS), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Lila |
Feisee |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations
PTO Administrative Reforms
Humanitarian Voucher
Three Track Examination
Generic Drug Patent Settlements
S. 3677: Financial Services and General Government Appropriations Act of 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 4213: American Jobs & Closing Tax Loopholes Act
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
Convention on Biological Diversity
DNA Patenting and Licensing
Amicus Matters
Bayh-Dole Act/Tech Transfer
Bayh-Dole Act/Tech Transfer
Commercialization of Federally Funded Research Initiative
Intellectual Property International Enforcement
Compulsory Licensing
17. House(s) of Congress and Federal agencies Check if None
State - Dept of (DOS), U.S. Trade Representative (USTR), Patent & Trademark Office (PTO), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Commerce - Dept of (DOC), Energy - Dept of, Office of Science & Technology Policy (OSTP), White House Office, Health & Human Services - Dept of (HHS), Agriculture - Dept of (USDA), Justice - Dept of (DOJ), Intl Trade Administration (ITA), Food & Drug Administration (FDA), Natl Economic Council (NEC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lila |
Feisee |
|
|
|
Hans |
Sauer |
|
|
|
Matthew |
Schumaker |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Cartier |
Esham |
|
|
|
Tom |
DiLenge |
|
|
|
Patrick |
Carroll |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
DelMonte |
|
|
|
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
for FY 2011
Funding for the Food and Drug Administration
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
for FY 2011
Genetically Engineered (GE) Animals
Labeling
FDA Approval
Drug Importation
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
for FY 2011
S. 3607: Department of Homeland Security Appropriations Act for FY 2011
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
for FY 2011
Generic Drug Patent Settlements
S. 3677: Financial Services and General Government Appropriations Act of 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 4213: American Jobs & Closing Tax Loopholes Act
Labeling of Genetically Engineered Crops
U.S. Government Policy
17. House(s) of Congress and Federal agencies Check if None
Agriculture - Dept of (USDA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), U.S. Trade Representative (USTR), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Bill |
Olson |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Matthew |
Schumaker |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Tom |
DiLenge |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
Algae-based Renewable Fuel/Carbon Capture and Conversion
Biofuels Production Tax Credit Modification for Algae-based Biofuels
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
S. 1250: Algae-based Renewable Fuel Promotion Act of 2009
Biofuels
Economic Growth Impact/Potential of Advanced Biofuels
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
Biofuels Production Tax Credit Extension
H.R. 5142 Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Funding
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
S: 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R.1586 / S.A.4575: Supplemental Education, Jobs and Medicaid Assistance Act of 2010
Domestic Manufacturing and Energy Jobs Act of 2010 (Discussion Draft)
Renewable Fuels Standard
Implementation of Energy Independence and Security Act of 2007
Regulatory Oversight
Biorefineries
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005
S.3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Modification of the Advanced Energy Products Tax Credit
Next Generation Incentive Tax Credit
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Bio-based Products
Tax Credit
Expansion of DOE and USDA Loan Guarantee Programs
Funding
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
S: 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R.1586 / S.A.4575: Supplemental Education, Jobs and Medicaid Assistance Act of 2010
Budget of the United States for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Energy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Bill |
Olson |
|
|
|
Amy |
Ehlers |
|
|
|
Patrick |
Carroll |
|
|
|
Paul |
Poteet |
|
|
|
Brent DelMonte |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Global Food Security Initiative
Funding
S.3676: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2011
U.S. Government Strategy
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
Genetically Engineered (GE) Animals
Labeling
FDA Approval
Labeling of Genetically Engineered Crops
U.S. Government Policy
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Agriculture - Dept of (USDA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
Bill |
Olson |
|
|
|
David |
Edwards |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Climate Change Benefits of Biofuels and Bio-based Products
Biogenic Carbon Emissions Accounting
Algae-based Renewable Fuel/Carbon Capture and Conversion
Biofuels Production Tax Credit Modification for Algae-based Biofuels
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
S. 1250: Algae-based Renewable Fuel Promotion Act of 2009
Biofuels
Economic Growth Impact/Potential of Advanced Biofuels
DOE Loan Guarantees and Grants under The Energy Policy Act of 2005 (Implementation and Funding)
Biofuels Production Tax Credit Extension
H.R. 5142 Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Funding
S.3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
S: 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R.1586 / S.A.4575: Supplemental Education, Jobs and Medicaid Assistance Act of 2010
Domestic Manufacturing and Energy Jobs Act of 2010 (Discussion Draft)
Renewable Fuels Standard
Implementation of Energy Independence and Security Act of 2007
Regulatory Oversight
Biorefineries
Funding for Reverse Auction Loan Program under Section 942 of the Energy Policy Act of 2005
S.3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
Modification of the Advanced Energy Products Tax Credit
Next Generation Incentive Tax Credit
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Bio-based Products
Tax Credit
Expansion of DOE and USDA Loan Guarantee Programs
Funding
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
S: 3635: Energy and Water Development and Related Agencies Appropriations Act for FY 2011
H.R.1586 / S.A.4575: Supplemental Education, Jobs and Medicaid Assistance Act of 2010
Budget of the United States for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Energy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Bill |
Olson |
|
|
|
Patrick |
Carroll |
|
|
|
Paul |
Poteet |
|
|
|
Amy |
Ehlers |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Drug Safety and Review
FDA Globalization Act (Discussion Draft)
E-Pedigree and Anti-Counterfeiting
Biodefense Research, Development and Procurement
S. 3761: A Bill to Restore Funding for Indian Loan Guarantee Program at the Bureau of Indian Affairs
HHS Countermeasures Review
H.R. 4899: Supplemental Appropriations Act of 2010
H.R. 5297: American Jobs and Closing Tax Loopholes Act of 2010
S. 3693: A Bill to Provide Funding for the Settlement of Lawsuits Against the Federal Government for
Discrimination Against Black Farmers
Pharmaceutical Industry Annual Fee
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Treasury and IRS Regulations Implementing the Law
Medicare Prescription Drug Coverage
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Nomination of Board Members for the Patient-Centered Outcomes Research Institute
Vaccine Access/Financing
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Expansion of 340B Drug Pricing Program
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010
S. 3793: Job Creation and Tax Cuts Act of 2010
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Federal Supply Schedule Access During Emergencies
S.2868: Federal Supply Schedules Usage Act of 2009
Alliance for Healthcare Competitiveness
Stem Cell Research
Federal Funding of Embryonic Stem Cell Research
Medicaid Rebates
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Therapeutic Discovery Project Tax Credit
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Drug Importation
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
S. 3607: Department of Homeland Security Appropriations Act for FY 2011
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Average Manufacturer Price Calculations
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Diagnostics and Personalized Medicine Regulation and Oversight
Draft Legislation
Rare Pediatric & Tropical Disease Drug Development
S. 3697: Creating Hope Act of 2010
Funding for the Food and Drug Administration
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2011
Funding for National Institutes of Health
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Act for FY 2011
Cures Acceleration Network
Funding:
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Act for FY 2011
Funding for Pandemic Influenza Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
Funding for Bioterrorism and Emergency Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
Funding for Biomedical Advanced Research and Development Authority (BARDA)
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
Funding for Strategic National Stockpile
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Funding for Centers for Disease Control and Prevention Vaccine Programs
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Act for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Internal Revenue Service (IRS), Treasury - Dept of, Natl Security Council (NSC), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), U.S. Trade Representative (USTR), White House Office, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shelly |
Mui-Lipnik |
|
|
|
Paul |
Poteet |
|
|
|
Laurel |
Todd |
|
|
|
Lauren |
Neff |
|
|
|
Andrew |
Emmett |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Cartier |
Esham |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Kelly |
Lai |
|
|
|
Sandra |
Dennis |
|
|
|
Alan |
Eisenberg |
|
|
|
Tooshar |
Swain |
|
|
|
Patrick |
Carroll |
|
|
|
Phyllis |
Arthur |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Strategic National Stockpile
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Biodefense Research, Development and Procurement
S. 3761: A Bill to Restore Funding for Indian Loan Guarantee Program at the Bureau of Indian Affairs
HHS Countermeasures Review
H.R. 4899: Supplemental Appropriations Act of 2010
H.R. 5297: American Jobs and Closing Tax Loopholes Act of 2010
S. 3693: A Bill to Provide Funding for the Settlement of Lawsuits Against the Federal Government for
Discrimination Against Black Farmers
Funding for Pandemic Influenza Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
Funding for Bioterrorism and Emergency Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
Funding for Biomedical Advanced Research and Development Authority (BARDA)
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
17. House(s) of Congress and Federal agencies Check if None
Natl Security Council (NSC), White House Office, U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melissa |
Bowie |
|
|
|
Anna |
Weinstein |
|
|
|
Phyllis |
Arthur |
|
|
|
Jeanne |
Haggerty |
|
|
|
Matthew |
Schumaker |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Nomination of Board Members for the Patient-Centered Outcomes Research Institute
Funding for Pandemic Influenza Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
Funding for Bioterrorism and Emergency Preparedness
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
Funding for Biomedical Advanced Research and Development Authority (BARDA)
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Act for FY 2011
H.R. 4899: Emergency Supplemental Appropriations Act for 2010
H.R. 1586/S.A. 4575: Supplemental Education, Jobs and Medicaid Assistance Act for FY 2011
Funding for National Institutes of Health
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Cures Acceleration Network
Funding:
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations Act for FY 2011
Stem Cell Research
Federal Funding of Embryonic Stem Cell Research
Biodefense Research, Development and Procurement
S. 3761: A Bill to Restore Funding for Indian Loan Guarantee Program at the Bureau of Indian Affairs
HHS Countermeasures Review
H.R. 4899: Supplemental Appropriations Act of 2010
H.R. 5297: American Jobs and Closing Tax Loopholes Act of 2010
S. 3693: A Bill to Provide Funding for the Settlement of Lawsuits Against the Federal Government for
Discrimination Against Black Farmers
Rare Pediatric & Tropical Disease Drug Development
S 3697: Creating Hope Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), U.S. Trade Representative (USTR), White House Office, Centers For Medicare and Medicaid Services (CMS), Natl Security Council (NSC), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Cartier |
Esham |
|
|
|
Anna |
Weinstein |
|
|
|
Melissa |
Bowie |
|
|
|
Phyllis |
Arthur |
|
|
|
Patrick |
Carroll |
|
|
|
Tom |
DiLenge |
|
|
|
Paul |
Poteet |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Prescription Drug Coverage
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Average Manufacturer Price Calculations
H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010
H.R. 4899: Emergency Supplemental Appropriations Act for FY 2010
Medicaid Rebates
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lauren |
Neff |
|
|
|
Matthew |
Schumaker |
|
|
|
Melissa |
Bowie |
|
|
|
Laurel |
Todd |
|
|
|
Jeanne |
Haggerty |
|
|
|
Anna |
Weinstein |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Stem Cell Research
Federal Funding of Embryonic Stem Cell Research
Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009
Research & Development Tax Credit Extension
H.R. 4213: American Jobs & Closing Tax Loopholes Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anna |
Weinstein |
|
|
|
Cartier |
Esham |
|
|
|
Paul |
Poteet |
|
|
|
Alan |
Eisenberg |
|
|
|
Jeanne |
Haggerty |
|
|
|
Melissa |
Bowie |
|
|
|
Matthew |
Schumaker |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009
Therapeutic Discovery Project Tax Credit
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Small Business Early-Stage Investment
H.R. 5297: Small Business Lending Fund Act of 2010
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS), Treasury - Dept of, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Paul |
Poteet |
|
|
|
Alan |
Eisenberg |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Tooshar |
Swain |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Pharmaceutical Industry Annual Fee
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Treasury and IRS Regulations Implementing the Law
Research & Development Tax Credit Extension
H.R. 4213: American Jobs & Closing Tax Loopholes Act
Election of R&D/AMT Tax Credits in Lieu of Bonus Depreciation
Senate Substitute to H.R. 5297: Small Business Lending Fund Act of 2010
Biofuels Production Tax Credit Modification for Algae-based Biofuels
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 5142 Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
S. 1250: Algae-based Renewable Fuel Promotion Act of 2009
Therapeutic Discovery Project Tax Credit
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Biorefineries
Modification of the Advanced Energy Products Tax Credit
Next Generation Incentive Tax Credit
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Biofuels Production Tax Credit Extension
H.R. 5142: Grow Renewable Energy Economy Now-Jumpstart Other Biofuels Act of 2010
Bio-based Products
Tax Credit
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS), Treasury - Dept of, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bill |
Olson |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Paul |
Poteet |
|
|
|
Laurel |
Todd |
|
|
|
Lauren |
Neff |
|
|
|
Cartier |
Esham |
|
|
|
Matt |
Carr |
|
|
|
Tooshar |
Swain |
|
|
|
Alan |
Eisenberg |
|
|
|
Amy |
Ehlers |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings
Foreign Agricultural Biotechnology Laws and Regulations
Discussions with EU on Animal Cloning
China Biotechnology Regulations
APEC Agricultural Biotechnology Discussions
Low-Level Presence Foreign Government Policies
Korea Biotechnology Regulations
EU Biotechnology Bilateral Discussions
Turkish Biotechnology Regulations
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Drug Importation
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
S. 3607: Department of Homeland Security Appropriations Act for FY 2011
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations
Act for FY 2011
Export Registrations for Products with Expired Patents
Alliance for Healthcare Competitiveness
U.S. Policy on International Science-Based Regulations
Intellectual Property International Enforcement
Compulsory Licensing
Transpacific Partnership
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
Convention on Biological Diversity
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Food & Drug Administration (FDA), Agriculture - Dept of (USDA), State - Dept of (DOS), Commerce - Dept of (DOC), Patent & Trademark Office (PTO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sharon |
Bomer Lauritsen |
|
|
|
David |
Edwards |
|
|
|
Matthew |
OMara |
|
|
|
Bill |
Olson |
|
|
|
Andrew |
Emmett |
|
|
|
Kelly |
Lai |
|
|
|
Lila |
Feisee |
|
|
|
Hans |
Sauer |
|
|
|
Tom |
DiLenge |
|
|
|
Paul |
Poteet |
|
. |
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Medicare Prescription Drug Coverage
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Comparative Effectiveness Program Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Nomination of Board Members for the Patient-Centered Outcomes Research Institute
Medicaid Rebates
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Drug Importation
S. 3606: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations
Act for FY 2011
S. 3607: Department of Homeland Security Appropriations Act for FY 2011
S. 3686: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2011
Drug Safety and Review
FDA Globalization Act (Discussion Draft)
E-Pedigree and Anti-Counterfeiting
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lauren |
Neff |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Anna |
Weinstein |
|
|
|
Andrew |
Emmett |
|
|
|
Melissa |
Bowie |
|
|
|
Patrick |
Carroll |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
Class Action Fairness Act Amendments
H.R. 5503: Securing Protections for the Injured from Limitations on Liability Act
Ban on Protective Orders
H.R. 5503: Securing Protections for the Injured from Limitations on Liability Act
Appointment of Registered Agents
H.R. 4678: Foreign Manufacturer Legal Accountability Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Schumaker |
|
|
|
Tom |
DiLenge |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |